Loading viewer...
conference
Format: PDF conference
MorphoSys AG held an investor and analyst conference call on February 6, 2024 regarding its acquisition by Novartis. The presentation covers details of the takeover offer, regulatory filing requirements, and forward-looking statements regarding the transaction timetable and conditions.
investor_presentation
25 Pages
conference
85 Pages
Marathon Petroleum
Regeneron Pharmaceuticals 2024 JPMorgan Healthcare Conference
conferenceconference
33 Pages
Regeneron Pharmaceuticals, Inc.